She described it almost apologetically. Every afternoon, about an hour after lunch, a wall comes down. Not ordinary tiredness, but the kind where reading the same email three times still doesn’t work. She’d mentioned it once, been tested, and been told her blood sugar was normal. She believed it. She just didn’t know what to do with the fact that she still felt this way.
Then she said the thing I hear most: “So I guess it’s just me.”
It isn’t. And the test wasn’t wrong. It was answering a different question than the one she was asking.
What your glucose test was designed to find
A fasting glucose or an A1c is built to detect one thing, and it detects it well: whether sugar is accumulating in your blood. That’s a serious question, and screening for it prevents real harm.
But sugar accumulating in your blood is the late event. For years beforehand, your body prevents it, and it does that with insulin.
When cells stop responding well to insulin, your pancreas doesn’t give up. It compensates. It makes more. And for as long as that compensation holds, your glucose stays where it should be, because the system is working. It’s just working at a rising cost that nothing on a standard panel measures.
Your glucose is normal because your body is working hard, not because it doesn’t have to.
The years before a diagnosis
This isn’t theory. There’s a study that watched it happen.
According to PubMed (DOI60619-X)), the Whitehall II study followed 6,538 British civil servants who did not have diabetes, testing them repeatedly over a median of nearly ten years. In the 505 people who eventually developed type 2 diabetes, researchers could then look backwards through their old results.
Insulin sensitivity dropped steeply across the five years before diagnosis. Fasting glucose stayed on a slow, unremarkable line, then turned sharply upward only in the final three years.
The compensation is visible in that same data. Beta-cell function rose between years four and three before diagnosis, then fell away. That’s the system working harder, and then not managing to.
That’s the whole point. For years the underlying problem was measurable and moving. The number most people get checked was not.
Nobody in that study was mismanaged. They were tested with the tool that exists, and that tool reports the last stage of a process that starts much earlier.
What might actually be happening after lunch
Now the part I want to be careful with. This is where health writing tends to overreach.
According to PubMed (DOI), researchers put continuous glucose monitors on 1,070 people across 8,624 standardized meals and more than 71,000 of their normal ones. What predicted how hungry people were afterwards wasn’t the peak after eating. It was the dip: the undershoot 2 to 3 hours later, when glucose drops below where it started.
People with bigger dips were hungrier, ate sooner, and ate more over the next 24 hours. The correlations were modest, a real signal rather than a large one. A larger insulin response would be expected to produce a steeper dip, so a plausible chain runs: reduced insulin sensitivity, a bigger insulin response to the same meal, a deeper trough after it, and symptoms in the window when you feel worst.
Here’s where I have to be honest with you. That study measured hunger and how much people ate next. It did not measure fatigue. So the link between a post-meal dip and the specific wall-of-exhaustion you’re describing is reasonable inference, not settled fact. I’d rather tell you that plainly than hand you a tidy explanation that outruns the evidence.
What I can say is this: post-meal exhaustion in someone with a normal glucose is not imaginary, and it is not automatically nothing.
The two things worth knowing before you test
Timing matters, and it’s easy to get wrong. Fasting insulin is a morning, nothing-to-eat-since-last-night test. If you’ve had coffee with milk, it isn’t a fasting result.
And the thresholds aren’t universal. According to PubMed (DOI), a further analysis of that same Whitehall cohort compared 120 South Asian and 867 white participants who went on to develop diabetes. The South Asian participants ran higher fasting and post-meal insulin before diagnosis, and lost insulin sensitivity faster. Same disease, different trajectory. If you’re South Asian, a result that looks unremarkable against a general reference range deserves a closer read.
What I’d ask for
If this is you, the conversation to have with your doctor is a short one. Alongside the glucose and A1c you’ve already had:
Fasting insulin. The measurement that shows the effort, not just the outcome.
HOMA-IR. Not a separate blood draw, just a calculation from your fasting glucose and fasting insulin together.
Triglycerides and HDL. Often an early signal, and usually already on a lipid panel you’ve had.
If it’s useful, I’ve written up how I approach metabolic health and insulin resistance, including which labs I run and what a standard workup tends to leave out.
And rule out the other causes properly, because post-meal fatigue is not one disease. Iron deficiency, thyroid dysfunction, celiac disease, sleep apnea, and several common medications all produce exactly this. A good workup looks at the whole list rather than falling in love with the first plausible answer.
The part I want you to take with you
A normal result is real information, and worth having. It means your body is still compensating. That’s good news, and it’s the reason there’s room to act.
What “normal” doesn’t tell you is how much it’s costing to stay that way.
You weren’t given the wrong test. You were given the test that answers a later question than the one your afternoons are asking. That isn’t a failure on anyone’s part, yours least of all.
If you’ve been told your sugars are fine and you still hit a wall after every meal, the next question isn’t what’s wrong with me. It’s what hasn’t been measured yet.
And if it does get measured and the number comes back high, that isn’t a worse outcome than not knowing. According to PubMed (DOI), the Diabetes Prevention Program randomized 3,234 people with raised glucose to placebo, metformin, or a lifestyle program built around 7% weight loss and 150 minutes of activity a week. Over an average of 2.8 years, the lifestyle arm cut new diabetes by 58% (95% CI 48 to 66), and it outperformed the drug.
That trial measured diabetes, not afternoons. But it answers the question sitting underneath yours.
In my experience, insulin sensitivity is one of the more responsive things I work with. It shifts with sleep, with what and when you eat, with muscle, with stress. Not always quickly. Not always all the way back. But this is not a number you’re stuck with.
If someone sent you this, they were probably trying to explain something they’ve struggled to put into words. The most useful thing you can offer isn’t advice. It’s going with them to the appointment, and saying out loud that you’ve seen it.
This is education, not a diagnosis or a prescription. Talk to your own physician before changing anything about your care, and don’t start, stop, or adjust any medication without medical guidance.
Want a workup that includes fasting insulin, not just glucose? Book a 90-minute consultation.
Sources & Research
All findings retrieved via PubMed.
Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215-2221. https://doi.org/10.1016/S0140-6736(09)60619-X60619-X)
Wyatt P, Berry SE, Finlayson G, et al. Postprandial glycaemic dips predict appetite and energy intake in healthy individuals. Nat Metab. 2021;3(4):523-529. https://doi.org/10.1038/s42255-021-00383-x
Hulman A, Simmons RK, Brunner EJ, et al. Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. Diabetologia. 2017;60(7):1252-1260. https://doi.org/10.1007/s00125-017-4275-6
Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https://doi.org/10.1056/NEJMoa012512
Get the next one as it's written.
New articles on hormones, gut health, thyroid, and metabolic health — free, by email, as soon as they publish.
